JP2014530837A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530837A5 JP2014530837A5 JP2014536252A JP2014536252A JP2014530837A5 JP 2014530837 A5 JP2014530837 A5 JP 2014530837A5 JP 2014536252 A JP2014536252 A JP 2014536252A JP 2014536252 A JP2014536252 A JP 2014536252A JP 2014530837 A5 JP2014530837 A5 JP 2014530837A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- optionally substituted
- general formula
- hal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 230000003612 virological effect Effects 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 239000003446 ligand Substances 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 206010022000 influenza Diseases 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 241000712892 Arenaviridae Species 0.000 claims 2
- 241000711573 Coronaviridae Species 0.000 claims 2
- 241000711950 Filoviridae Species 0.000 claims 2
- 241000710781 Flaviviridae Species 0.000 claims 2
- 241000700586 Herpesviridae Species 0.000 claims 2
- 241000712464 Orthomyxoviridae Species 0.000 claims 2
- 241000711504 Paramyxoviridae Species 0.000 claims 2
- 241000150350 Peribunyaviridae Species 0.000 claims 2
- 241000709664 Picornaviridae Species 0.000 claims 2
- 241000712907 Retroviridae Species 0.000 claims 2
- 241000711931 Rhabdoviridae Species 0.000 claims 2
- 241000710924 Togaviridae Species 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 claims 1
- 101800004538 Bradykinin Proteins 0.000 claims 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims 1
- 102100035792 Kininogen-1 Human genes 0.000 claims 1
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 claims 1
- 229940123424 Neuraminidase inhibitor Drugs 0.000 claims 1
- 229940123066 Polymerase inhibitor Drugs 0.000 claims 1
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 claims 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims 1
- 229930003827 cannabinoid Natural products 0.000 claims 1
- 239000003557 cannabinoid Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 229940125400 channel inhibitor Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000002911 sialidase inhibitor Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550045P | 2011-10-21 | 2011-10-21 | |
| US61/550,045 | 2011-10-21 | ||
| PCT/EP2012/070757 WO2013057251A2 (en) | 2011-10-21 | 2012-10-19 | Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530837A JP2014530837A (ja) | 2014-11-20 |
| JP2014530837A5 true JP2014530837A5 (OSRAM) | 2015-12-03 |
| JP6047168B2 JP6047168B2 (ja) | 2016-12-21 |
Family
ID=47178587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014536252A Expired - Fee Related JP6047168B2 (ja) | 2011-10-21 | 2012-10-19 | ヘテロアリールヒドロキサム酸誘導体及びウイルス性疾患の治療、改善又は予防におけるその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20130102600A1 (OSRAM) |
| EP (1) | EP2776396A2 (OSRAM) |
| JP (1) | JP6047168B2 (OSRAM) |
| KR (1) | KR20140100476A (OSRAM) |
| CN (1) | CN103958475B (OSRAM) |
| BR (1) | BR112014001369A2 (OSRAM) |
| CA (1) | CA2852750A1 (OSRAM) |
| HK (2) | HK1199640A1 (OSRAM) |
| MX (1) | MX2014003803A (OSRAM) |
| RU (1) | RU2014120421A (OSRAM) |
| WO (1) | WO2013057251A2 (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014177514A1 (en) | 2013-04-30 | 2014-11-06 | Bayer Cropscience Ag | Nematicidal n-substituted phenethylcarboxamides |
| CA2953862A1 (en) | 2014-07-07 | 2016-01-14 | F. Hoffmann-La Roche Ag | Dihydropyridopyrazine-1,8-diones and their use in the treatment, amelioration or prevention of viral diseases |
| JP2017525777A (ja) * | 2014-08-28 | 2017-09-07 | エックス−ケム，インコーポレーテッド | 可溶性エポキシドヒドロラーゼ阻害剤及びこれらの使用 |
| AU2016256125B9 (en) | 2015-04-28 | 2020-02-20 | Shionogi And Co., Ltd. | Substituted polycyclic pyridone derivative and prodrug thereof |
| PL3290424T3 (pl) | 2015-04-28 | 2023-05-08 | Shionogi & Co., Ltd | Podstawione policykliczne pochodne pirydonu i ich prolek |
| US20170081331A1 (en) | 2015-09-18 | 2017-03-23 | F. Hoffmann-La Roche Ag | Pyrazolopyrazines and their use in the treatment, amelioration or prevention of a viral disease |
| CR20180356A (es) | 2015-12-15 | 2018-08-22 | Shionogi & Co | Un medicamento caracterizado por combinar un inhibidor de la endonucleasa cap-dependiente del virus de la influenza y un fármaco anti-influenza |
| WO2018001948A1 (en) | 2016-06-29 | 2018-01-04 | F. Hoffmann-La Roche Ag | Pyridazinone-based broad spectrum anti-influenza inhibitors |
| KR20190007517A (ko) | 2016-08-10 | 2019-01-22 | 시오노기세야쿠 가부시키가이샤 | 치환된 다환성 피리돈 유도체 및 그의 프로드러그를 함유하는 의약 조성물 |
| AU2017320088B2 (en) * | 2016-09-05 | 2020-01-30 | Guangdong Raynovent Biotech Co., Ltd. | Anti-influenza virus pyrimidine derivative |
| EP4271383A4 (en) * | 2020-12-29 | 2024-10-23 | Merck Sharp & Dohme LLC | Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5475109A (en) | 1994-10-17 | 1995-12-12 | Merck & Co., Inc. | Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease |
| US6680385B2 (en) * | 2002-01-25 | 2004-01-20 | The Hong Kong Polytechnic University | Catalytic preparation of aryl methyl ketones using a molecular oxygen-containing gas as the oxidant |
| US7550463B2 (en) | 2004-09-15 | 2009-06-23 | Shionogi & Co., Ltd. | Carbamoylpyridone derivatives having inhibitory activity against HIV integrase |
| WO2010100475A1 (en) * | 2009-03-02 | 2010-09-10 | Astrazeneca Ab | Hydroxamic acid derivatives as gram-negative antibacterial agents |
| WO2010110231A1 (ja) | 2009-03-26 | 2010-09-30 | 塩野義製薬株式会社 | 置換された３－ヒドロキシ－４－ピリドン誘導体 |
| TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
| WO2011000566A2 (en) | 2009-06-30 | 2011-01-06 | Savira Pharmaceuticals Gmbh | Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections |
-
2012
- 2012-10-18 US US13/655,394 patent/US20130102600A1/en not_active Abandoned
- 2012-10-19 RU RU2014120421/04A patent/RU2014120421A/ru not_active Application Discontinuation
- 2012-10-19 EP EP12786860.2A patent/EP2776396A2/en not_active Withdrawn
- 2012-10-19 BR BR112014001369A patent/BR112014001369A2/pt not_active IP Right Cessation
- 2012-10-19 HK HK14113138.0A patent/HK1199640A1/xx unknown
- 2012-10-19 WO PCT/EP2012/070757 patent/WO2013057251A2/en not_active Ceased
- 2012-10-19 CA CA2852750A patent/CA2852750A1/en not_active Abandoned
- 2012-10-19 KR KR1020147013723A patent/KR20140100476A/ko not_active Withdrawn
- 2012-10-19 HK HK14110437.4A patent/HK1197059A1/xx unknown
- 2012-10-19 MX MX2014003803A patent/MX2014003803A/es unknown
- 2012-10-19 JP JP2014536252A patent/JP6047168B2/ja not_active Expired - Fee Related
- 2012-10-19 CN CN201280051750.0A patent/CN103958475B/zh not_active Expired - Fee Related
-
2016
- 2016-04-06 US US15/091,632 patent/US20160297763A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530837A5 (OSRAM) | ||
| JP2016518305A5 (OSRAM) | ||
| JP2015517555A5 (OSRAM) | ||
| JP2014530838A5 (OSRAM) | ||
| RU2014120421A (ru) | Производные гетероарилгидроксамовой кислоты и их применение при лечении, облегчении течения или профилактике вирусных заболеваний | |
| JP2015521189A5 (OSRAM) | ||
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| JP2016530259A5 (OSRAM) | ||
| JP2016508145A5 (OSRAM) | ||
| RU2015107803A (ru) | Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания | |
| JP2016515560A5 (OSRAM) | ||
| JP2016503797A5 (OSRAM) | ||
| JP2011201907A5 (OSRAM) | ||
| JP2017537940A5 (OSRAM) | ||
| JP2013537203A5 (OSRAM) | ||
| JP2010502730A5 (OSRAM) | ||
| JP2016006118A5 (OSRAM) | ||
| JP2013508279A5 (OSRAM) | ||
| JP2013512277A5 (OSRAM) | ||
| PE20141124A1 (es) | Derivados de imidazol fusionados, utiles como inhibidores de ido | |
| JP2014500295A5 (OSRAM) | ||
| HRP20140501T1 (hr) | Derivati benzazepina korisni kao antagonisti vazopresina | |
| JP2020532545A5 (OSRAM) | ||
| JP2015521156A5 (OSRAM) | ||
| JP2013509392A5 (OSRAM) |